Endoscopic Ultrasonography-Guided Ethanol Injection for a Pancreatic Neuroendocrine Tumor with Multiple Endocrine Neoplasia Type 1.
10.15279/kpba.2016.21.4.202
- Author:
Sujong AN
1
;
Jae Yong LEE
;
Sung Ha HWANG
;
Do Hyun PARK
;
Sung Koo LEE
Author Information
1. Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea. sklee@amc.seoul.kr
- Publication Type:Case Report
- Keywords:
Multiple endocrine neoplasia type 1;
Pancreas;
Neuroendocrine tumors;
Endosonography;
Ethanol
- MeSH:
Chromosomes, Human, Pair 1;
Endosonography;
Ethanol*;
Female;
Humans;
Islets of Langerhans;
Multiple Endocrine Neoplasia Type 1*;
Multiple Endocrine Neoplasia*;
Neuroendocrine Tumors*;
Pancreas
- From:Korean Journal of Pancreas and Biliary Tract
2016;21(4):202-208
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
Multiple endocrine neoplasia type 1 (MEN1) is a rare inherited disorder caused by mutations in the MEN1 gene on chromosome 1. Clinical diagnostic criteria for MEN1 include the presence of two or more endocrine tumors such as pituitary, parathyroid, and pancreatic islet tumors. Treatment is needed for tumors accompanied by symptoms or having malignant potential. Malignant neuroendocrine tumors (NETs) are the major cause of MEN1-related death, and pancreatic NETs account for 30-80% of MEN1 cases. Surgery is the mainstay curative treatment, and endoscopic intervention is a treatment option when patients are poor candidates for surgery. A 33-year old female patient with MEN1 was treated via endoscopic ultrasonography-guided ethanol injection for a pancreatic NET.
